Claire Wartelle-Bladou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claire Wartelle-Bladou has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Christophe Renou
2 shared publicationsAlexandre Pariente
Centre Hospitalier de Pau, ClinSearch
1 shared publicationAndré Glibert
Centre Hospitalier de Tarbes, ClinSearch
1 shared publicationBernard Nalet
Centre Hospitalier de Montélimar, ClinSearch
1 shared publicationDaniel Fischer
Centre Hospitalier d’Evry, ClinSearch
1 shared publicationDenis Grasset
Centre Hospitalier de Montauban, ClinSearch
1 shared publication
Latest Publications
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , -846-846
T1013 A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)
- 31 May 2009
- Published by Elsevier in Gastroenterology
- Vol. 136 (5) , -846-846
T1013 A Multicentric, Double-Blind, Randomized Placebo-Controlled Trial of High Dose Ursodeoxycholic Acid in Patients with Non-Alcoholic Steatohepatitis (NASH)
- 1 March 2008
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 32 (3) , S96-S108
Adhésion à la bithérapie pégylée au cours de l’hépatite chronique C
- 1 March 2008
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 32 (3) , S96-S108
Adhésion à la bithérapie pégylée au cours de l’hépatite chronique C
- 30 October 2007
- Vol. 31, 4S51-5
[Management of hepatitis C among drug user patients].
Opiate substitution treatments radically changed the care management of HCV among drug user patients. Thanks to substitution, it is possible to treat HCV among these patients even with ongoing drug abuse. Overall, in terms of response to treatment, observance, adverse side effects and premature interruptions of treatment, the results are comparable with those observed among non drug addict patients. It is advisable nevertheless to create specific conditions which favour this total care management. The non-invasive fibrosis tests largely improve access to care as compared to liver biopsy. A multidisciplinary team is essential in addressing the associated problem of addiction, hepatitis C and psychiatric co-morbidities. HCV prevails strongly among patients in centres for drug users. These structures are particularly adapted to the management of HCV with the assistance of multidisciplinary teams and access to the non-invasive tests.
- 30 October 2007
- Vol. 31, 4S51-5
[Management of hepatitis C among drug user patients].
Opiate substitution treatments radically changed the care management of HCV among drug user patients. Thanks to substitution, it is possible to treat HCV among these patients even with ongoing drug abuse. Overall, in terms of response to treatment, observance, adverse side effects and premature interruptions of treatment, the results are comparable with those observed among non drug addict patients. It is advisable nevertheless to create specific conditions which favour this total care management. The non-invasive fibrosis tests largely improve access to care as compared to liver biopsy. A multidisciplinary team is essential in addressing the associated problem of addiction, hepatitis C and psychiatric co-morbidities. HCV prevails strongly among patients in centres for drug users. These structures are particularly adapted to the management of HCV with the assistance of multidisciplinary teams and access to the non-invasive tests.
- 1 April 2006
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 30 (4) , 525-532
High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C
- 1 April 2006
- Published by Elsevier in Gastroentérologie Clinique Et Biologique
- Vol. 30 (4) , 525-532
High dose daily interferon-alpha induction and secondary adjunction of ribavirin in treatment-naive patients with chronic hepatitis C